Abstract
AbstractThe elderly are currently the most frequent users of antidepressants across ages, despite having a high risk of adverse effects (AEs). This literature review critically reviews the current evidence of the effectiveness of antidepressants and AEs in the elderly and discusses methodological limitations and future directions. Elements of Preferred Reporting Items for Systematic reviews and Meta‐Analyses and Population, Intervention, Control, and Outcomes guidelines were applied. Search in Scopus, PubMed, PsycInfo/Ovid, Cochrane Library, and Google Scholar for relevant systematic‐ and meta‐reviews on effectiveness and AEs studies. Ten reviews were identified and summarized within the last decade. Studies showed only modest superiorities to placebo in response rates if any, and only a few studies reached significant remission. Moreover, there was evidence of lower efficacy for patients over 65. AEs were common and problematic among the elderly in the studies reporting them. The evidence of the benefits of antidepressants in the elderly was weak and alternative treatments are advised. Despite the lack of clear evidence for the efficacy, UK National Institute for Health and Care Excellence guidelines have not incorporated separate recommendations for the elderly.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
